BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/26/2018 11:38:21 AM | Browse: 907 | Download: 1836
 |
Received |
|
2018-08-07 01:31 |
|
Peer-Review Started |
|
2018-08-07 06:07 |
|
First Decision by Editorial Office Director |
|
2018-08-24 10:23 |
|
Return for Revision |
|
2018-08-27 06:28 |
|
Revised |
|
2018-09-20 10:59 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2018-09-27 06:18 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2018-10-05 23:04 |
|
Articles in Press |
|
2018-10-05 23:04 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-10-15 05:26 |
|
Publish the Manuscript Online |
|
2018-10-26 11:38 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Second-line rescue treatment of Helicobacter pylori infection: Where are we now?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Te-Fu Lin and Ping-I Hsu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ping-I Hsu, MD, Attending Doctor, Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, 386 Ta Chung 1st Road, Kaohsiung 813, Taiwan. williamhsup@yahoo.com.tw |
| Key Words |
Helicobacter pylori; Rescue treatment; Levofloxacin-amoxicillin triple therapy; Bismuth quadruple therapy; Tetracycline-levofloxacin quadruple therapy; High-dose dual therapy |
| Core Tip |
The present article reviews current second-line anti-Helicobacter pylori (H. pylori) regimens. Bismuth quadruple therapy and levofloxacin-amoxicillin triple therapy have comparable eradication rates in the rescue treatment of H. pylori infection, while the former has more adverse effects than the latter. High-dose dual therapy has an eradication rate comparable with levofloxacin-amoxicillin triple therapy. Ten-day tetracycline-levofloxacin quadruple therapy achieves a markedly higher eradication rate compared with levofloxacin-amoxicillin triple therapy (98% vs 69%) in patients with failure of standard triple, bismuth quadruple or non-bismuth quadruple therapy. In conclusion, tetracycline-levofloxacin quadruple therapy has the potential to become a universal second-line treatment for H. pylori infection. |
| Publish Date |
2018-10-26 11:38 |
| Citation |
Lin TF, Hsu PI. Second-line rescue treatment of Helicobacter pylori infection: Where are we now? World J Gastroenterol 2018; 24(40): 4548-4553 |
| URL |
http://www.wjgnet.com/1007-9327/full/v24/i40/4548.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v24.i40.4548 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
